• 1. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 2. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 3. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 4. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 5. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Guanidines Biguanides

Recent Advances in the Study of N-(diaminomethylene)piperazine-1-carboxamidine (CAS: 19207-57-9) in Chemical Biology and Pharmaceutical Research

N-(diaminomethylene)piperazine-1-carboxamidine (CAS: 19207-57-9) is a compound of significant interest in chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. Recent studies have explored its role as a versatile building block in drug discovery, particularly in the development of small-molecule inhibitors targeting various enzymes and receptors. This research brief synthesizes the latest findings on this compound, highlighting its synthesis, biological activity, and potential applications in medicine.

One of the most notable advancements in the study of N-(diaminomethylene)piperazine-1-carboxamidine is its application in the design of kinase inhibitors. Kinases play a critical role in cellular signaling pathways, and their dysregulation is implicated in numerous diseases, including cancer and inflammatory disorders. Researchers have successfully incorporated this compound into novel inhibitor scaffolds, demonstrating potent and selective inhibition of specific kinase targets. For instance, a 2023 study published in the Journal of Medicinal Chemistry reported the development of a series of inhibitors featuring this moiety, which exhibited nanomolar potency against a key oncogenic kinase.

Beyond its role in kinase inhibition, N-(diaminomethylene)piperazine-1-carboxamidine has also been investigated for its potential in antimicrobial drug development. The compound's ability to interact with bacterial enzymes and disrupt essential metabolic pathways has made it a promising candidate for addressing antibiotic resistance. Recent in vitro studies have shown that derivatives of this compound exhibit broad-spectrum activity against multidrug-resistant bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum β-lactamase (ESBL)-producing Escherichia coli.

The synthetic accessibility of N-(diaminomethylene)piperazine-1-carboxamidine has further contributed to its popularity in medicinal chemistry. Recent methodological improvements have enabled more efficient and scalable synthesis routes, facilitating its incorporation into diverse chemical libraries. A 2024 publication in Organic Process Research & Development detailed an optimized, high-yield synthesis protocol that reduces production costs and environmental impact, making the compound more accessible for large-scale pharmaceutical applications.

In addition to its direct therapeutic applications, research has explored the compound's utility as a molecular probe in chemical biology. Its ability to form stable complexes with various biomolecules has enabled researchers to study protein-ligand interactions and cellular processes with unprecedented precision. Advanced biophysical techniques, such as surface plasmon resonance (SPR) and isothermal titration calorimetry (ITC), have been employed to characterize these interactions, providing valuable insights for structure-based drug design.

Looking ahead, the versatility of N-(diaminomethylene)piperazine-1-carboxamidine suggests continued importance in pharmaceutical research. Ongoing studies are investigating its potential in targeted drug delivery systems and as a component of PROTACs (proteolysis targeting chimeras), which represent a promising approach in drug discovery. As research progresses, this compound is likely to play an increasingly significant role in addressing unmet medical needs across multiple therapeutic areas.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)